神経チャネル病の新規治療薬開発の基盤となるモデル細胞及びスクリーニング系の確立

• Project/Area Number: 25K02581
• Research Category: Grant-in-Aid for Scientific Research (B)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 52020:Neurology-related
• Research Institution: The University of Osaka
• Principal Investigator: 久保田 智哉 大阪大学, 大学院 医学系研究科, 准教授 (20573231)
• Project Period (FY): 2025-04-01 – 2028-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥18,850,000 (Direct Cost: ¥14,500,000、Indirect Cost: ¥4,350,000); Fiscal Year 2027: ¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000); Fiscal Year 2026: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000); Fiscal Year 2025: ¥9,230,000 (Direct Cost: ¥7,100,000、Indirect Cost: ¥2,130,000)